CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

被引：0
|
作者：
Onali, S. [1 ]
Di, Petrillo A. [1 ]
Favale, A. [1 ]
Carpineti, C. [1 ]
Cadoni, M. [1 ]
Loddo, E. [1 ]
Fantini, M. C. [1 ]
机构：
[1] Univ Cagliari, Med Sci & Publ Healt, Cagliari, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2023年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T.06.1
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [41] Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
    Tillack, Cornelia
    Ehmann, Laura Maximiliane
    Friedrich, Matthias
    Laubender, Ruediger P.
    Papay, Pavol
    Vogelsang, Harald
    Stallhofer, Johannes
    Beigel, Florian
    Bedynek, Andrea
    Wetzke, Martin
    Maier, Harald
    Koburger, Maria
    Wagner, Johanna
    Glas, Juergen
    Diegelmann, Julia
    Koglin, Sarah
    Dombrowski, Yvonne
    Schauber, Juergen
    Wollenberg, Andreas
    Brand, Stephan
    GUT, 2014, 63 (04) : 567 - 577
  • [42] IFN-gamma and IL-4 promote TH1 and TH2 development by differentially modulating high affinity IL-12 receptor expression and IL-12-induced activation of Stat1 and Stat5.
    Gollob, JA
    Mahajan, S
    Rudders, SA
    Ritz, J
    Frank, DA
    BLOOD, 1996, 88 (10) : 1100 - 1100
  • [43] Heterogenous infiltration of surface Th1 marker (CCR5) and Th2 marker (CRTH2) cells in colonic mucosa of patients with Crohn's disease.
    Yoshida, Y
    Hokari, R
    Matsuzaki, K
    Kato, S
    Iwai, A
    Kurihara, C
    Kawaguchi, A
    Nagao, S
    Okada, Y
    Itoh, K
    Miura, S
    Nagata, K
    GASTROENTEROLOGY, 2001, 120 (05) : A523 - A523
  • [44] Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression
    Kaser, A
    Kaser, S
    Kaneider, NC
    Enrich, B
    Wiedermann, CJ
    Tilg, H
    BLOOD, 2004, 103 (02) : 648 - 655
  • [45] Infliximab Treatment Modified Immune Profile, Associating With Improved TH1/TH2 Balance and Immunoregulatory T-Cell Expression, in Immunomodulator NaIve Crohn's Disease Patients With Short Duration
    Fukunaga, Ken
    Kamikozuru, Koji
    Hida, Nobuyuki
    Ohda, Yoshio
    Yoshida, Koji
    Yokoyama, Yoko
    Kikuyama, Risa
    Kato, Kyoichi
    Takeda, Naohisa
    Nakamura, Shiro
    Miwa, Hiroto
    Matsumoto, Takayuki
    GASTROENTEROLOGY, 2010, 138 (05) : S423 - S423
  • [46] Intestinal TIGITnegCD38+memory T cells proliferate, acquire an ex-Th17/Th1*pathogenic phenotype and drive inflammation in severe Crohn's disease patients with poor outcome
    Heredia, Maud
    Barendregt, Danielle M. H.
    Tindemans, Irma
    Klomberg, Renz C. W.
    Aardoom, Martine A.
    Calado, Beatriz
    Costes, Lea M. M.
    Joosse, M. E.
    Hulleman-van Haaften, Danielle H.
    Tuk, Bastiaan
    van Berkel, Lisette A.
    Kemos, Polychronis
    Ruemmele, Frank
    Croft, Nick
    Escher, Johanna C.
    de Ridder, Lissy
    Samsom, Janneke N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1317 - 1317
  • [47] The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease
    Li, Mingxuan
    Yang, Chuanyu
    Wang, Yunhai
    Song, Wei
    Jia, Lina
    Peng, Xiaoxiang
    Zhao, Ronglan
    JOURNAL OF IMMUNOLOGY, 2020, 205 (07): : 1752 - +
  • [48] The expression IL1B correlates negatively with the clinical response to adalimumab in Crohn's disease patients: An ex vivo approach using peripheral blood mononuclear cells
    Gole, Boris
    Pernat, Cvetka
    Jezernik, Gregor
    Potocnik, Uros
    LIFE SCIENCES, 2023, 326
  • [49] Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn's disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort
    An, Y-K
    Lindsay, N.
    Allan, N.
    Khoo, E.
    Amiss, A.
    Moniruzzaman, M.
    Fernandes, R.
    Ooi, S-Y
    Thin, L.
    Lightowler, D.
    Connor, S.
    Williams, A-J
    De Cruz, P.
    Suen, C. Li Wai
    Kariyawasam, V.
    Mitrev, N.
    Ghaly, S.
    Andrews, J. M.
    Christensen, B.
    Sparrow, M.
    White, L.
    Bryant, R. V.
    Ding, N.
    Leong, R.
    Van Langenberg, D.
    Seltenreich, H.
    Subramaniam, K.
    Radford-Smith, G.
    Begun, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 146 - 147
  • [50] Mucosal tissue derived factors (MTDF) from patients with active Crohn's disease (CD) downregulates IL10 receptor expression on normal human intestinal primary epithelial cells (HIPEC).
    Zhao, LM
    Burakoff, R
    Panja, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1112 - A1112
12345